SASTASUNDR2023-07-012023-09-30 SASTASUNDR2023-07-012023-09-30 SASTASUNDR2023-07-012023-09-30in-bse-fin:OneOtherRevenueFromOperations01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourOtherRevenueFromOperations01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member SASTASUNDR2023-09-30 SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentRevenue01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentRevenue02Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourReportableSegmentRevenue01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourReportableSegmentRevenue02Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentResults01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentResults02Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourReportableSegmentResults01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourReportableSegmentResults02Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentAssets01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentAssets02Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentLiabilities01Member SASTASUNDR2023-09-30in-bse-fin:OneReportableSegmentLiabilities01Member SASTASUNDR2023-09-30 SASTASUNDR2023-07-012023-09-30in-bse-fin:OneReportableSegmentLiabilities02Member SASTASUNDR2023-09-30in-bse-fin:OneReportableSegmentLiabilities02Member SASTASUNDR2023-07-012023-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member SASTASUNDR2023-07-012023-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 533259 SASTASUNDR NOTLISTED Sastasundar Ventures Limited Equity 2023-04-01 2024-03-31 2023-11-10 2023-10-31 INR Lakhs Half yearly 2023-11-10 14:00:00 2023-11-10 16:40:00 true Cash Flow Indirect Not applicable Multi segment 2023-07-01 2023-09-30 Unaudited Consolidated 1804000.00 975000.00 0.00 0.00 -27727000.00 0.00 3534558000.00 19609000.00 55718000.00 3584937000.00 97076000.00 3682013000.00 7329000.00 3251927000.00 -56461000.00 129080000.00 2430000.00 22025000.00 0.00 0.00 0.00 0.00 219319000.00 3575649000.00 106364000.00 0.00 106364000.00 40984000.00 -65548000.00 -24564000.00 130928000.00 0.00 0.00 0.00 -252965000.00 -122037000.00 3180000.00 -118857000.00 -81137000.00 -40900000.00 -78915000.00 -39942000.00 318105000.00 10 -2.55 -2.55 0.00 0.00 -2.55 -2.55 0.00 0.00 0.00 4. Exceptional items represent the gain on following transaction/ event: (a) During the previous year, the management based on its internal assessment, has detected misappropriation of cash collections from customers aggregating to Rs. 796.45 lakhs (Sastasundar Healthbuddy Limited- Rs. 161.40 Lakhs) (Retailer Shakti Supply Chain Pvt Ltd- Rs. 635.05 Lakhs) by few employees of the Sastasundar Healthbuddy Limited (“SHBL”), subsidiary of the company and Retailer Shakti Supply Chain Pvt Ltd (RSCPL), step down subsidiary of the company. SHBL has referred the matter to the police department and after filing of the First Information Report (FIR), the aforesaid employees were arrested by the police and an investigation charge sheet has been filed with the Additional Chief Judicial Magistrate, Baruipur, West Bengal by the police. SHBL and RSCPL has expensed the aforesaid amount during the previous year under the heading “exceptional item” and the SHBL is taking necessary legal action to recover the amount. 5. Happymate Foods Limited, step down subsidiary of the company had started its operation in fast moving consumer goods in 2018 with an aim to reach the consumer with a premium brand. The company has taken various steps since then to build distribution channel & offline stores, which did not turn out as expected and losses has been incurred. Presently the company is into discussion with business partner on further plans of restructuring its business. 6. During the current quarter, Sastasundar Healthbuddy Limited (SHBL) subsidiary of the Company'Trade Payables as of Sep 30, 2023 are net of debit note balance of Rs. 887.71 lakhs related to the return of goods (generally medicine). There is a time lag between issue of credit notes by the suppliers against the debit notes raised by the Company. The management is in the process of matching the debit note with corresponding credit note issued by the vendor and reconciling the outstanding balance of debit notes as at Sep 30, 2023. 7. Sastasundar Healthbuddy Limited (SHBL) subsidiary of the Company's has received 99,873 number of 0.01% Non-Cumulative Compulsorily Convertible Preference Shares (CCPS) from its associate (erstwhile wholly owned subsidiary) in the earlier financial year. SHBL has entered into a Put Call Option Agreement on 19 November 2021 with its associate and the purchaser (‘the investor’) (the Holding Company of the associate) whereby it agreed to sell 75.1% of the aforesaid CCPS (‘milestone shares’) to the investor at a specified consideration on achievement of certain milestones on or before the milestone event target dates by the Company. The put call option agreement was subsequently amended on 3 March 2022 and 17 April 2023. As per the last amendment, SHBL agreed to transfer 12,612 CCPS to the investor for an agreed consideration, against which Rs. 1,669.23 lakhs was received in May 2023, and 4,182 CCPS to be converted into equity shares of the associate as per the conversion ratio defined in the agreement, post achievement of the specified milestones. With respect to the remaining CCPS, it was decided that SHBL, the associate and the investor will mutually discuss and agree in writing the terms and conditions of the remaining milestone events, milestone shares and milestone consideration. The maximum overall consideration payable for all milestones has been specified by the amendment agreement dated 17 April 2023 which is in line with the amended Put Call Option Agreement dated 3 March 2022. The management, based on its internal assessment and best estimate of milestone events, milestone shares and milestone consideration, has derived the fair value of the investment for the aforesaid CCPS by engaging an independent registered valuer. Multi segment 2023-04-01 2023-09-30 Unaudited Consolidated 3591000.00 1178000.00 0.00 0.00 28511000.00 0.00 6816551000.00 38568000.00 57020000.00 6945419000.00 218136000.00 7163555000.00 11957000.00 5971529000.00 170496000.00 247603000.00 4920000.00 42958000.00 0.00 0.00 0.00 0.00 417445000.00 6866908000.00 296647000.00 0.00 296647000.00 87589000.00 -167021000.00 -79432000.00 376079000.00 0.00 0.00 0.00 -500974000.00 -124895000.00 -311000.00 -125206000.00 -68068000.00 -56827000.00 -68437000.00 -56769000.00 318105000.00 10 -2.14 -2.14 0.00 0.00 -2.14 -2.14 0.00 0.00 0.00 Other Financial Income 55718000.00 Other Financial Income 57020000.00 Other expenses 219319000.00 Other expenses 417445000.00 83780000.00 19918000.00 0.00 403073000.00 0.00 81526000.00 5196330000.00 2924879000.00 8709506000.00 1631461000.00 43500000.00 20482000.00 25120000.00 0.00 671573000.00 4959000.00 0.00 361434000.00 754000.00 433338000.00 3192621000.00 11902127000.00 318105000.00 7147462000.00 9810438000.00 0.00 0.00 75148000.00 587693000.00 0.00 0.00 0.00 0.00 0.00 87436000.00 177542000.00 927819000.00 269336000.00 51422000.00 760960000.00 82152000.00 1163870000.00 11902127000.00 Financial Services 30771000.00 Healthcare Services 3554166000.00 Financial Services 90301000.00 Healthcare Services 6855118000.00 3584937000.00 6945419000.00 0.00 0.00 3584937000.00 6945419000.00 Financial Services 25639000.00 Healthcare Services -1596000.00 Financial Services 78873000.00 Healthcare Services 24689000.00 24043000.00 103562000.00 2430000.00 4920000.00 -84751000.00 -198005000.00 106364000.00 296647000.00 Financial Services 652331000.00 Healthcare Services 10735554000.00 11387885000.00 514242000.00 11902127000.00 Financial Services 14151000.00 Healthcare Services 2070068000.00 2084219000.00 7470000.00 2091689000.00 2. The Group has identified the following segments : (a) Financial Services - consists mainly of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution and related services. (b) Healthcare Network - includes activities for pathology, food processing and marketing of healthcare and OTC products through e-commerce portal and diagnostic services which consist of pathological / radiological investigations. Remeasurement gain/(loss) on defined benefit plans 3165000.00 Remeasurement gain/(loss) on defined benefit plans -417000.00 3165000.00 -417000.00 -15000.00 -106000.00 3180000.00 -311000.00 4920000.00 176857000.00 -66573000.00 0.00 28054000.00 0.00 -1649000.00 -71198000.00 0.00 97514000.00 0.00 248000.00 0.00 42958000.00 0.00 0.00 -1646000.00 14910000.00 -5816000.00 0.00 1178000.00 131568000.00 0.00 -67389000.00 0.00 -70042000.00 0.00 18273000.00 0.00 -33325000.00 263322000.00 0.00 0.00 0.00 58608000.00 0.00 204714000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3120000.00 37935000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 880477000.00 3024984000.00 0.00 0.00 0.00 0.00 1178000.00 130142000.00 0.00 1614774000.00 0.00 -433228000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4920000.00 0.00 0.00 -4920000.00 -233434000.00 0.00 -233434000.00 317214000.00 83780000.00